Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation.

Hematol Transfus Cell Ther

Bone Marrow Transplant and Cellular Therapy, Tisch Cancer Institute, The Mount Sinai Hospital, New York, NY, USA.

Published: January 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627859PMC
http://dx.doi.org/10.1016/j.htct.2021.11.019DOI Listing

Publication Analysis

Top Keywords

daratumumab donor-specific
4
donor-specific anti-hla
4
anti-hla antibody
4
antibody desensitization
4
desensitization case
4
case hla-mismatched
4
hla-mismatched allogeneic
4
allogeneic stem
4
stem cell
4
cell transplantation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!